Log In
Print
BCIQ
Print
Print this Print this
 

Monovisc

  Manage Alerts
Collapse Summary General Information
Company Anika Therapeutics Inc.
DescriptionSingle injection device that delivers hyaluronic acid from a non-animal source
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat pain caused by osteoarthritis (OA); Treat pain caused by osteoarthritis (OA) of the hip; Treat pain caused by osteoarthritis (OA) of the knee
Regulatory Designation

Partner

Johnson & Johnson


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2.5M

$2.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today